Compare KITT & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KITT | BNGO |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | 47 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 11.6M |
| IPO Year | N/A | 2018 |
| Metric | KITT | BNGO |
|---|---|---|
| Price | $0.72 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | ★ 2.4M | 115.4K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | $2,936.06 | N/A |
| Revenue Next Year | N/A | $24.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.69 | $1.06 |
| 52 Week High | $6.93 | $5.50 |
| Indicator | KITT | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 36.63 |
| Support Level | N/A | $1.06 |
| Resistance Level | $1.06 | $1.18 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 8.21 | 40.79 |
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.